Key statistics
On Friday, GeneDx Holdings Corp (WGS:NSQ) closed at 40.40, -6.74% below its 52-week high of 43.32, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.59 |
---|---|
High | 43.32 |
Low | 40.01 |
Bid | 40.00 |
Offer | 40.40 |
Previous close | 40.65 |
Average volume | 405.89k |
---|---|
Shares outstanding | 26.94m |
Free float | 20.09m |
P/E (TTM) | -- |
Market cap | 1.09bn USD |
EPS (TTM) | -4.51 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
- GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
- GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
- GeneDx to Participate in Upcoming Investor Conferences
- GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
- GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
- GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
- GeneDx to Participate in 44th Annual Cowen Health Care Conference
- GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
More ▼